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Abstract
Background: The suboptimal rate of viral suppression among persons aged 13 years and older and residing in 37 states and the
District of Columbia leaves considerable opportunities for onward transmission and contributes to poor health outcomes. Men
who have sex with men (MSM) represent one of the most at-risk groups in the United States. There is a clear and continued need
for innovative adherence support programs to optimize viral suppression. To address this gap, we designed and are implementing
a randomized controlled trial (RCT) to test the efficacy of the Thrive with Me intervention for MSM living with HIV. Critical
components of the protocol are presented.
Objective: The aim of this study is to describe the protocol for rigorously testing the efficacy of Thrive with Me to improve
antiretroviral therapy (ART) adherence among HIV-positive MSM residing in New York City.
Methods: A community advisory board and beta testing were used to obtain feedback from HIV-positive MSM on the overall
look and feel of Thrive with Me and problems with navigation to finalize intervention components and content. We will enroll
400 HIV-positive MSM residing in the New York City area into a two-arm prospective RCT and follow them for 17 months.
Men in the Thrive with Me experimental intervention arm will have access to Thrive with Me for 5 months. Thrive with Me has
three primary components: (1) a private social networking feature; (2) tailored HIV and ART adherence information; and (3)
medication reminders, self-monitoring, and reflection. Gamification components include badges and leveling up to increase
intrinsic motivation to engage with the intervention. Men randomized to the control condition will view a weekly newsletter for
5 months. The newsletter will be delivered via email and contains information on topics related to HIV with the exception of
ART adherence. Study assessments will occur at enrollment and 5, 11, and 17 months post enrollment. The primary study outcome
is HIV viral load, which is considered an objective indicator of ART adherence.
Results: Participant recruitment for the RCT began in October 2016, and the data collection period is anticipated to end in the
Fall of 2019.
Conclusions: The efficacy trial of Thrive with Me will help to fill gaps in understanding about the utility of multicomponent,
technology-based interventions to improve ART adherence among HIV-positive MSM. Of importance is the ability for the results
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of the Thrive with Me trial to inform best practices for conducting technology-based interventions that incorporate social media
features.
Trial Registration: ClinicalTrials.gov NCT02704208; https://clinicaltrials.gov/ct2/show/NCT02704208 (Archived by WebCite
at http://www.webcitation.org/6zQ8WPra6)
Registered Report identifier: RR1-10.2196/10182
(JMIR Res Protoc 2018;7(5):e10182)   doi:10.2196/10182
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Introduction
Background
HIV rates in the United States, for the most recent 5 years data
that are available, have declined slightly from 14.2 new HIV
diagnoses per 100,000 in 2010 to 12.3 in 2015 [1]. Despite
decreases in HIV infection rates among injection drug users,
women, and heterosexual men, those attributed to male-to-male
sexual contact remain stable. In 2015, 70% of all new HIV
infections were attributed to male-to-male sexual contact
(including the category of male-to-male sexual contact and
injection drug use) [1]. Current US Guidelines for the Use of
Antiretroviral Agents [2] state that undetectable viral load (VL)
“is one of the most reliable indicators of adherence,” which is
largely achieved though sufficient and sustained adherence to
antiretroviral therapy (ART). Optimal ART adherence reduces
excess morbidity and mortality among people living with HIV
or AIDS (PLWH) [3] and lowers the probability of forward
transmission to sexual partners [4]. However, in a review of
studies of the treatment cascade for men who have sex with
men (MSM), viral suppression was between 16% and 42%
among the 7 reported studies conducted in the United States
[5]. The most recent Centers for Disease Control and Prevention
(CDC) surveillance data showed that 61% of MSM diagnosed
with HIV in 37 states and the District of Columbia had VL
below 200 copies/mL [6], although viral suppression is estimated
to be lower among all people aware and unaware of their
HIV-positive status (49%) [7]. Despite the disproportionate
burden of HIV in MSM communities, only three of 13
medication adherence interventions included in CDC’s
Compendium of Evidence-based Behavioral Interventions
include a majority MSM participants; the first is a provider
implemented approach evaluated over a decade ago [8], the
second is an intensive one-on-one counseling approach [9], and
the third is an individual-level, computerized, clinic-based
counseling intervention [10]. Thus, advancing tailored and
innovative ART adherence interventions for HIV-positive MSM
remains a high priority [11].
The use of technology has rapidly grown since 2000, when only
52% of US adults used the internet [12]. Currently, 88% of US
adults are online [12], 95% own a cell phone [13], 75% own a
smartphone [13], and 68% use Facebook [14]. Technology-based
ART adherence approaches have proliferated in recent years
[15,16] because of the widespread adoption of technology across
sociodemographic groups [12], their ability to reach a broad
audience, and their low implementation costs [17]. However,
computerized ART adherence interventions [10,18], including
those specifically for MSM [19] and illicit drug users [20], tend
to be individually delivered and do not leverage peer-to-peer
interactivity that has come to symbolize Web 2.0 [19]. Peer
support interventions may facilitate user-generated content
through wall or message board posts that create unique social
incentives to maintain high engagement in the intervention.
In-person peer support ART adherence interventions have shown
moderate success in improving adherence outcomes [21,22].
Simoni and colleagues randomized 224 HIV-positive patients
at a public HIV specialty clinic in Seattle, Washington to receive
either in-person peer support, pager messaging, both in-person
peer support and pager messaging, or usual care [22] for a
3-month period. Assessments occurred every 3 months for a
total of 9 months. Participants who received the peer intervention
reported higher self-reported adherence at the immediate
postintervention assessment, although intervention effects
diminished at later assessment periods. Only the pager
intervention showed significant effects for improving biological
outcomes, suggesting that other adherence supports may be
needed to bolster peer support–only interventions.
In response to the growing use of technology and the limitations
of in-person ART adherence peer support interventions, we
developed and pilot tested the Thrive with Me (TWM)
intervention. TWM is a virtual (ie, online) behavioral
intervention that includes peer-to-peer communication features,
tailored ART and HIV information, and an ART self-monitoring
component. TWM is grounded in the information-
motivation-behavioral Skills (IMB) model [23,24]. We
conducted a pilot study of TWM from February 2010 to April
2010 to assess its feasibility, acceptability, and preliminary
efficacy among 123 adult MSM (mean age=43 years; 64.2%,
79/123 white) mostly recruited online in the United States. A
full description of the study and its results has been published
[25]. Briefly, results showed that 90.2% (111/123) were retained
at the final assessment, and there were high acceptability ratings
among men assigned to the TWM condition. Although overall
adherence scores showed modest improvement from baseline
to follow-up among the TWM intervention group compared
with the control condition, these differences were not statistically
significant. Among MSM who reported recent (<30 days) illicit
drug use (16.3%, 20/123 of the sample), those in the TWM
condition reported significantly higher overall ART adherence
and ART taken correctly with food than those in the control
condition.
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Figure 1. Thrive with Me intervention components and the information-motivation-behavioral skills (IMB) model. ART: antiretroviral therapy.
Study Aims
The results of the TWM pilot study suggest that the approach
of combining peer support, ART information, and adherence
self-monitoring may improve ART adherence among MSM,
especially those who use illicit drugs. This paper describes the
protocol for a randomized controlled trial (RCT) to assess the
efficacy of the TWM intervention to improve ART adherence
among adult HIV-positive MSM. The aims of the study were
as follows:
Primary aim 1: determine the efficacy of the TWM
intervention to increase the proportion of virally
suppressed HIV-positive MSM at postintervention
time points.
Hypothesis 1: a higher proportion of participants in
the TWM intervention than control participants will
have undetectable VL at postintervention time points.
Primary aim 2: assess whether the TWM intervention
is more beneficial for HIV-positive MSM who report
recent drug use at baseline compared with
HIV-positive MSM who do not.
Hypothesis 2: recent drug-using participants in the
TWM intervention will demonstrate greatest
improvements in VL and self-reported ART adherence
at postintervention time points compared with
nondrug-using participants.
We also propose the following secondary aims:
Secondary aim 3: examine the effects of the TWM
intervention on sustained undetectable VL, defined
as having an undetectable VL at all postbaseline
assessment time points.
Secondary aim 4: examine the effects of the TWM
intervention on theory-based change process (ie, IMB
factors and social support) for improving VL, ART
adherence, illicit drug use outcomes, and engagement
in HIV care.
Theoretical Basis for Intervention
The IMB model proposes that health behavior change occurs
through the provision of relevant information, personal and
social motivation to engage in the behavior, and appropriate
behavioral skills to enact the behavior [26,27]. The associations
between core TWM intervention components (described in
detail below) and the IMB model components are shown in
Figure 1.
The IMB model has been evaluated and supported using
clinic-based samples in Puerto Rico [24], Italy [28], and
Mississippi [29]. Using data collected as part of a pilot trial of
TWM [30], our team investigated whether the IMB model is a
useful predictive model of ART adherence among PLWH who
were primarily recruited online and whether the theorized
associations between IMB model constructs and adherence
persisted in the presence of depression and current drug use
[31]. Participants were on average 43 years of age, had been
living with HIV for 9 or more years, and mostly male (84.0%,
270/312), white (68.8%, 222/312), and gay-identified (74.8%,
241/312). Using a revised version of the IMB scales, IMB
constructs were associated with adherence as predicted by the
theory among nondrug users and those with and without
depression. However, among drug users, information exerted
a direct effect on adherence but was not significantly associated
with behavioral skills. These results suggest that the IMB model
is an appropriate theoretical foundation for TWM, even when




The research activities include a prospective two-arm RCT to
test the efficacy of TWM to improve ART adherence among
approximately 400 adult gay and bisexual MSM residing in the
New York City area (Figure 2). TWM is a multisite study
between the University of Minnesota (UMN) in Minneapolis
and the Center for HIV Educational Studies and Training
(CHEST), which is part of Hunter College, City University of
New York. The team in Minnesota, led by principal investigator
(PI) Dr Horvath, developed the TWM intervention, scientific
protocols, and all training documents for implementation. The
team at CHEST, led by coinvestigator Dr Parsons, manages the
recruitment, enrollment, and retention of all participants.
Following screening and enrollment, participants are randomized
to either the experimental (TWM) or control arm. Men in the
experimental arm receive access to the TWM intervention for
a period of 5 months, whereas those in the control arm receive
weekly emails with HIV-relevant content that does not include
information about ART adherence. Assessments are conducted
in-person at the CHEST offices by trained research personnel
and occur for participants in both arms of the study at baseline,
5-month, 11-month, and 17-month follow-up time points. The
primary outcome measure for the RCT is VL at the three
follow-up assessment time points. We hypothesize that a higher
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proportion of participants in the TWM intervention than control
participants will have undetectable VL at postintervention time
points. We also hypothesize that recent drug-using participants
in the TWM intervention will demonstrate greatest
improvements in VL and self-reported ART adherence at
postintervention time points compared with nondrug-using
participants.
As secondary analyses, we will assess whether sustained
undetectable VL, defined as having an undetectable VL across
all follow-up assessment points, is higher among men in the
TWM intervention condition. We will also assess the degree to
which self-reported, theoretically derived adherence barriers
(information, motivation, and behavioral skills) and social
support within and outside the TWM intervention are associated
with VL, self-reported ART adherence, illicit drug use outcomes,
and engagement in HIV care.
Participants
Men residing in the New York City metropolitan area will be
recruited by CHEST staff to participate in this study. New York
City was chosen as an ideal location to conduct the study
because of the high numbers of HIV-infected MSM residents
[1] and since only 38% of residents with HIV are estimated to
be virally suppressed [32]. The eligibility criteria are shown in
Textbox 1.
Additionally, a 50% target enrollment of drug-using (including
powder cocaine, crack cocaine, painkillers, methamphetamine,
heroin, hallucinogens, prescription drugs used recreationally,
ketamine, MDMA, and poppers) men was established to ensure
that both drug-using and nondrug-using men were enrolled in
the trial. Due to its common use among HIV-positive and
HIV-negative or unknown MSM [33], we did not include users
who reported only marijuana use in the drug-using category.
Figure 2. Participants' flow through the Thrive With Me study.
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Textbox 1. Eligibility criteria.
Eligibility criteria
• Current male gender
• Having sex with a man in the past year
• HIV-positive serostatus (confirmed by current antiretroviral therapy prescription when possible)
• Reporting a detectable viral load (past year) or potentially suboptimal ART adherence (<90% in the past 30 days)
• English proficiency (as the intervention is in English)
• Residing in the New York City metropolitan area (so that men can attend in-person study visits)
• The ability to send and receive short message service messages
• Having internet access over the active (ie, 5 month) study period
Randomization
Randomization occurs once participants are consented and
enrolled in TWM. Participants complete a baseline
computer-assisted survey instrument (CASI) programmed using
Qualtrics (Provo, UT). At the end of the survey, a research
assistant enters a password that enables Qualtrics to randomize
the participant to either the experimental or control arm.
Randomization was programmed using blocks of 20 (10
intervention and 10 control) to ensure we had enough users in
the social network throughout data collection. After
randomization, participants are further stratified by recent drug
use and nonrecent drug use. Participants are not informed about
their assigned arm in terms of intervention or active control, as
the arms are described to participants simply as group 1 and
group 2.
Recruitment
Participants will be recruited by staff at CHEST, which utilizes
both active (eg, direct outreach) and passive (eg, advertising in
clinic settings and internet-based) recruitment approaches to
effectively recruit HIV+ MSM into intervention trials. CHEST
has successfully developed a carefully monitored and organized
recruitment structure through both internet- and field-based
recruitment efforts. Recruitment efforts involve a preliminary
screening process that significantly reduces the number of
study-specific screeners conducted by project staff. CHEST
uses internet recruitment efforts through online venues that cater
to MSM and other populations that are most affected by HIV
(eg, Grindr, Scruff, Adam4Adam, Craigslist, Facebook,
Instagram, Twitter, and other social media platforms), as well
as utilizing email distribution lists and blogs that expand to
hard-to-reach populations through connections with nightlife
party promoters, sex party promoters, and other
community-based leaders or organizations. In addition to
internet-based recruitment efforts, CHEST has utilized
field-based recruitment strategies in their efforts for reaching
HIV-positive MSM from diverse communities, ethnic and racial
backgrounds, and sexual identity. Recruiters will conduct on-site
preliminary screening via tablets at local bars, clubs, and
community events frequented by gay and bisexual men in the
New York City area. If a participant is determined to be
preliminarily eligible for TWM, they are asked to provide
contact information (including name, phone number, and email
address) so that a study staff can contact them to perform the
full study screener.
During the screening process, participants will be asked if they
participated in the beta testing phase of TWM or are currently
enrolled in TWM. Responding “yes” to either question will
result in ineligibility. Eligible participants’ contact information
(email, phone number, first and last name) will be automatically
cross-referenced with enrolled participant information to capture
duplicate participants before baseline and enrollment.
Intervention
Thrive With Me Condition
Several strategies were employed to ensure sustainability,
accessibility, and high user acceptance of TWM. To promote
sustainability, the software team developed the program on a
well-supported, open source, Web development framework and
content management system, future-proofing the site against
vendor lock-in and providing a platform for delivering a rich
feature set within the resource constraints of the project. To
promote accessibility, the user experience design team utilized
a “responsive Web” approach, wherein the site layout
dynamically adapts to suit the size and capability of the user’s
device (eg, cell phone, tablet, or laptop). This ensured that TWM
was available across a variety of devices and eliminated the
need for multiple mobile device–specific codebases (eg, native
apps). Finally, throughout development, the team sought input
from representative users regarding the program interface,
features, and design style, increasing the likelihood of high user
acceptance upon release.
The active intervention period is 150 days (approximately 5
months). Men in the TWM experimental intervention arm have
access to the full TWM website that has three primary
components: (1) a private social networking feature (Figure 3);
(2) tailored HIV and ART adherence information (Figure 4);
and (3) medication reminders, self-monitoring, and reflection
(Figure 5). Privacy on the TWM site was prioritized in several
ways. First, TWM was designed to be a closed community, such
that only participants could gain access to enter the site. Second,
because of stigma that HIV-positive MSM commonly face and
concerns that some participants may feel uncomfortable
disclosing their identities online, we established community
rules that men could not post pictures of themselves on the site.
Men could choose from a number of avatars that gave them the
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opportunity to tailor their profile without disclosing their
identity.
Using asynchronous peer-to-peer interaction, the TWM website
was developed to be a safe space for supportive peer-to-peer
interactions to promote healthy choices related to living with
HIV and medication adherence (Figure 3). Men are encouraged
to participate in the TWM social network as much as they are
comfortable, similar to other social networking sites. TWM is
moderated daily by research staff to identify any posts that
appear to reflect self or other harm intentions or behavior, any
hostile interactions, or misinformation that is not corrected by
group members. TWM staff members post to the feed a few
times a week to welcome new members to the site, remind
participants of some features of the site, and to announce the
winner of a weekly prize drawing for those who are very active
on the site.
The TWM website presents HIV-related content to users every
day in the form of Thrive Tips (Figure 4). Thrive Tips are
content pieces (text, images, videos) that address barriers to
medication adherence. There are 300 total Thrive Tips that are
released 3 to 4 per day, each tied to an individual item in the
IMB ART Adherence Questionnaire (IMB-AAQ; described
below). Thrive Tips that reflect a participant’s unique ART
adherence barrier are shown with a blue triangle in the corner
of the tip to indicate to him that the information is particularly
relevant to his needs. The longer participants are in the
intervention, Thrive Tips are accumulated and stored in an online
searchable library. Thrive Tips can be searched by category of
information, content recommended for the specific user, content
that has been favorited by the user, and tag words. Men retake
the IMB-AAQ at the midpoint of the intervention, and all Thrive
Tips are displayed again, although reflecting participant’s
updated adherence barrier profile.
In addition, men receive daily short message service (SMS)
reminders to take their medication at a time of their choosing.
Men receive follow-up SMS messages asking them to report
whether they took their dose that day (or not) and what their
current mood is (Figure 5). Once a week, participants are
reminded to complete their “weekly check-in,” where they are
shown their responses to the daily SMS messages and are asked
to report on which days in the prior week they used substances
(which could include alcohol and drugs). To encourage
reflection, men are then prompted to answer a multiple choice
question about how their week was overall (ie, “Looking back
at your week, how did you handle the tough things you had to
do? 1 hot mess; 2 fell on my face; 3 don’t stop me now; 4 I will
survive; 5 Sasha Fierce”) and are given a private text area to
record anything from the week that they want to remember. The
response options asking men to rate how their week was overall
were intended to be engaging to the user, rather than to collect
validated data on their perceptions of the quality of their week.
Therefore, we did not assess beforehand whether HIV-positive
MSM interpreted these items as ordinal. Participants may review
past weeks of responses during the active intervention period.
Figure 3. Thrive With Me peer interaction.
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Figure 4. Thrive with Me “Thrive Tip”.
In addition to these three primary components of the TWM
intervention, other features of the site include (1) A profile page
where men can update their profile and settings, gaming features
(eg, points, achievements, and badges; Figure 6); (2) A weekly
prize drawing of a US $25 online gift card for those who use
the site 5 or more times in the past 10 days; (3) An “About us”
page that describes the study and the study team; and (4) A
“Getting started” page that provides instructions about how to
use the TWM site. Access to the TWM site is given to
participants who have the correct username and password and
to study staff with the appropriate credentials (Figure 7).
Control Condition
Participants assigned to the control condition receive a weekly
email with content similar to a newsletter for 21 consecutive
weeks. Each email contains a link with information on a topic
related to living with HIV and devoted to improving general
well-being but not specifically about ART adherence. Sample
topics of the information-only control content include HIV and
longevity, HIV and parenting, and HIV and depression. Control
content is developed in, and sent from, Qualtrics, to allow for
the collection of data on which emails participants open. In
addition, at the bottom of each informational page is the question
“How would you rate this week’s content?” with a 5-star rating
from the numeric anchors 1 to 5.
Both the TWM intervention and the control intervention weekly
emails are viewable across multiple devices, including
smartphone devices, tablet computers, and desktop and laptop
computers.
Participant Monitoring and Monitoring Adverse
Events
Participant Monitoring
Participants will be informed during the consent process of the
“group rules” regarding interactions with one another (eg,
“Honesty is important, however, hostile or abusive language
will not be tolerated and may be grounds for immediate removal
from the study”). These “rules” will also be available with a
link on the TWM site. The project coordinator will manually
review each day posts that participants write to each other to
flag hostile interactions and inaccurate information. Hostile
interactions between participants will be handled by, first,
reminding the participants in the interaction of the “group rules”
regarding appropriate interactions. If the hostility continues, the
offending participants will be given a warning that the continued
hostility will result in withdrawal from the study if it continues.
On the third offense, the offending participant will be withdrawn
from the study. Text containing hostile exchanges will be
removed from the study website and unavailable to view. In
cases in which inaccurate information is found, project staff be
guided by exerts on the team to post a comment that provides
accurate information on the topic.
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Figure 5. Thrive with Me adherence, mood, and substance use self-monitoring.
Monitoring Adverse Events
Study staff will identify adverse events (AEs) and serious
adverse events (SAEs) that may occur during the study period.
Such events will be immediately brought to the attention of the
PI and the investigator team. AEs will be reported to the UMN
Institutional Review Board (IRB; 1504S69721) within 5 working
days. In the event that the UMN IRB requests follow-up reports
regarding an AE, it is the responsibility of the study Pl to submit
the report on or before the date requested by the IRB. SAEs will
be reported to the UMN IRB and National Institute on Drug
Abuse (NIDA) within 72 hours. Subsequent follow-up reports
for a specific SAE will be submitted quarterly (ie, every 3
months) to NIDA. The follow-up report on any specific SAE
will include correspondence from the IRB as to the
determination of whether the SAE was related to the study. In
the event that the UMN IRB requests follow-up reports
regarding an SAE, it is the responsibility of the Pl to submit the
report on or before the date requested by the IRB. The UMN
IRB has the authority to suspend or terminate approval of any
research at its site that has been associated with unexpected
serious harm to participants. The conditions under which the
study would be stopped include, but are not limited to, a direct
causal link between the study conditions and the hospitalization,
impairment, or death of any research participants. Finally, a
data safety and monitoring board (DSMB) will be convened to
determine safe and effective conduct and recommend conclusion
of a trial if significant risks develop or the trial is unlikely to be
concluded successfully. The board will consist of three experts




Seven men who had participated in prior research at CHEST
and indicated that they wanted to contribute to further research
were given contact information for the TWM study site
coordinator. Upon expressing interest in serving on a community
advisory board (CAB), they were given a brief phone screening
to ensure they were male-identified, at least 18 years of age,
HIV-positive, currently on ART medications, lived in New York
City, English speaking (as materials would all be in English),
and had access to the internet. Four members of the CAB
identified as African American or black, three identified as
white, and two identified as Hispanic or Latino. CAB members
were asked to complete three online surveys over the course of
2 months and were compensated US $50 per survey.
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Figure 6. Thrive with Me profile and gamification.
The first CAB survey gathered input on general user experience,
particularly aesthetics, language, and usability. For aesthetics,
we asked questions about a variety of color palettes and stock
photography. Users were asked to rank favorites, given scales
of adjective choices to describe aesthetics (ie, traditional vs
modern or informal vs formal) and also were given free text
options to include other feedback. Language questions were
focused on wording of medication reminder SMS text messages,
name choices for major features, what words we should use
when talking about illicit drugs, and the naming of various
badges and achievements. The second CAB survey was used
to gather input for HIV-related content that was not directly tied
to medication adherence. Suggestions regarding what topics to
discuss mostly informed the development of content for the
control arm. The third survey solicited feedback on a large
assortment of avatar choices for user’s profiles, from abstract
choices to different portrayals of people. It also included
questions about a weekly self-monitoring component to assess
clarity, usability, and overall tone of the language.
Beta Testing
A total of 16 men were recruited to beta test the TWM
intervention. Beta testing included collecting both usability (ie,
testing for navigation and technical errors) and acceptability
(ie, gathering feedback about the intervention features, functions,
and design) data. Inclusion criteria were male-identified, living
in the NYC metropolitan area, HIV-positive, currently on ART
medications, self-reported issues with medication adherence,
English-speaking (as the website is in English), access to the
internet, able to send and receive SMS messages, and available
for follow-up interview.
Eligible men visited CHEST offices in person for two visits
during beta testing. During the first visit, men completed a
baseline CASI on which a majority of participants identified as
non-Hispanic (81%, 13/16) and African American (75%, 12/16).
The average age was 36 years. The majority of participants
identified as homosexual or gay (94%, 15/16). Participants had
been diagnosed with HIV for a mean of 11.6 years. All
participants reported a history of lifetime drug use, whereas 13
(81%, 13/16) reported any drug use in the previous 30 days.
With respect to ART adherence, participants on average missed
3.7 doses in the past 30 days.
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Figure 7. Thrive with Me log-in page.
After completing the baseline CASI, participants met
individually with staff from CHEST for an orientation to the
TWM website. CHEST personnel demonstrated all of the core
components of the site from a desktop computer. Participants
were also given the opportunity to log in on their mobile phones.
Participants were given a “workbook” of tasks to complete on
the TWM site over the next 2 weeks and note anything they
liked, disliked, problems they encountered, or suggestions for
improvement. Participants then scheduled their second visit for
approximately 14 days later and were given US $50 for
compensation. The first visit typically lasted 90 to 120 min in
duration.
During the 2 weeks that men were using the website, research
staff from the UMN and CHEST in New York City
communicated daily about any technical challenges, participant
questions, or other concerns. After 2 weeks of testing the
website, participants returned to the offices of CHEST, and staff
there facilitated a phone interview between the UMN study
coordinator and the participant. The purpose of the call was to
gain feedback from participants about problems they
encountered as they used TWM, as well as their suggestions
for improving the overall look and feel of the intervention. Users
were logged into the TWM website during the telephone
interview, and participants also had their notes from the
workbook if they remembered to bring it with them to the second
visit. Interviews typically lasted between 30 to 45 min, and
participants were paid another US $50 to compensate for their
time. All 16 participants completed both visits.
Beta testing feedback and how the feedback was incorporated
(or not) into the final version of the TWM site is shown in Table
1. Most participants expressed positive opinions about the core
features of the site; however, there were several areas in which
participants noted opportunities for improvement. Feedback
included both content and site design requests, as well as
technical issues. Content feedback was incorporated into edits
made by the UMN research team, whereas feature requests and
technical issues were passed on to site developers. High priority
feature requests included changing aspects of the site that were
confusing or ungainly, increasing the customizability of users’
profiles, and altering the SMS reminder and check-in process.
Low-priority feature requests were an orientation to using the
site on a smartphone and more personalized options for the site.
Following a final revision of the TWM site based on feedback
from beta testing, enrollment into the RCT (Figure 2) began in
November 2016.
Outcomes
The study outcomes below are organized as shown in Table 2.
Measures are collected using an online survey tool (Qualtrics)
at baseline and 5-month, 11-month, and 17-month postbaseline
assessment time points. A table of measures administration is
shown in Table 2.
JMIR Res Protoc 2018 | vol. 7 | iss. 5 | e10182 | p.10http://www.researchprotocols.org/2018/5/e10182/
(page number not for citation purposes)
Horvath et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Table 1. Participant feedback from beta testing of the Thrive with Me (TWM) site.
Action takenParticipant recommendationsDislikesLikesTopic
Used more discrete language
(multivitamin instead of dose)
as default message; Mood re-
sponses updated; Changes to
greeting messages and discon-
tinued “goodbye” message
New or different options to de-
scribe emotions, new valedic-
tion
“Sometimes it just says ‘bye’
at the end of the text message
and that’s a little brief. Like
maybe say something else or
don’t say anything at all.”
“The med reminders are amazing
because they hit on the point, the
exact time that I set it for, so it
helps so much!...It helps me take
my meds every day.”
SMSa reminders
Added Thrive Tips to the first
week of the intervention
specifically orienting partici-
pants to the intervention;
Added Thrive Tips to the final
2 weeks of the intervention
regarding finding social sup-
port after TWM, closure
within the intervention and
“graduating” from TWM
“I think it’s amazing...that it
gives you tips and like things I
didn’t even know. I was like
that’s awesome! I think they’re
very helpful.”
Thrive tips
Updated layout of some Web
pages; Added an icon for a
phone’s home screen and
provided participants instruc-
tions for setting the icon
More mobile-friendly design
and features, icon on phone's
home screen
“On the phone, I don’t know,
it was more difficult to see
everything, you had to scroll
up and down and left and
right and it was just hard to
use.”
“On the computer it looked really
nice and I liked the layout, like
Facebook.”
Mobile features
Updated file size to accommo-
date larger images or graphic
interchange formats; Built
notification system to track
comments and likes within the
TWM site (no text, email, or
banner notifications were
added)
Larger maximum file size for
uploads to post on the wall, no-
tification when one's post is
commented on or liked
“I wouldn’t use it for that. I
mean, I don’t really want to
engage with people who I
don’t know.”
“It was kind of helpful because
I read how other people—how
they expressed their emotions,
how they felt, what they were
going through…so it kind of
helps you in your day by day so
you don’t feel like you’re alone.”
Social features
Increased avatar choices and
added features requested by
participants (glasses, afros,
more feminine looking op-
tions, etc); Added “Talk to me
about” feature with “check all
that apply” responses for a
variety of topics related to
HIV and general well-being
More diverse options for
avatars, profile questions about
HIV-related or life-related expe-
riences
“I don’t like the avatars at all.
I’m half something and half
something else with blue
hair…It looks like a muppet.”
“Avatar choices are cute, they
didn’t have faces, they are
anonymous, but there should be
more choices.”
Profile
Added a “Getting Started with
TWM” Web page to explain
all components of the interven-
tion; Updated in-person web-
site orientation to include
more details about achieve-
ments
More clarity about what earns
points and what badges mean
“Badges, achievements, I
didn’t understand it. What are
these points? Am I getting
money at the end of the day?
Why am I doing this?”
“They were cute, very
cute…They’re uplifting, you
know, you never know what
someone is going through and
some people are never told that
they do anything right. The
badges tell you ‘good job’.”
Achievements
N/AN/Ab“For people newly diagnosed
or early in their diagnosis this
would be a very very useful
tool…but for me personally
it’s just not practical. I don’t
need the things that it offers.”
“I mean we walk around with
HIV, I have HIV positive friends,
but a lot of times the only interac-
tion I would have around HIV
positive people would be around
sex, so this kind of brings it
around, where having that conver-
sation brings it out of the sexual
realm and maybe more into the
supportive realm, for people who
may not have that already.”
Overall
aSMS: short message service.
bN/A: not applicable.
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Table 2. Schedule of measures administration. An “X” indicates that the measure was assessed at the corresponding time point. A “—” indicates that










XXXXUndetectable=VL<20 copies/mLViral load (VL)
Demographics and HIV history
———XAge in yearsAge
———XRace, ethnicity (Hispanic or Latino)Race or ethnicity
XXXXSexual orientationSexual orientation
XXXXHighest level of education completedEducation
XXXXEmployment status, student statusEmployment
XXXXHousehold income, number dependents on incomeIncome
XXXXPopulation of residenceCommunity
XXXXType of health care coverageHealth insurance
Medical or clinical variables
———XYear and month diagnosed with HIV, AIDS diagnosisSelf-reported HIV history
Self-reported ARTa adherence
XXXXNumber of prescribed medications, vitamins, and sup-
plements
Prescriptions
XXXXYear started HIV medications, HIV medications current-
ly taken, number of doses per day
Antiretroviral medications
XXXXDoses missed (past 4 days, 30 days), % adherence (past
30 days), % taken within 2 hours of scheduled dose (past
Adherence
30 days), how good a job in taking HIV medications,
challenges to adherence






XXXXART adherence behavioral skillsBehavioral skills
Engagement in HIV care
XX——Last HIV care appointment, appointments scheduled





XXXXCocaine, methamphetamines, marijuana, and opiatesUrinalysis
XXXXAlcohol Use Disorders Identification Test Alcohol
XXXXDrug use (lifetime) and frequency (past 30 days) of 14




XXXXCenter for Epidemiological Studies-Depression 10-item
scale measuring depressive symptoms in past week
Depression
XXXXPerceived stress in past 30 daysStress
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XXXXMeasure of Life ChaosLife chaos
XXXXHIV Stigma Scale (internalized, anticipated, enacted)HIV stigma
XXXXHIV resilience itemsResiliency
Relationship and sexual risk
XXXXRelationship status, relationship sexual agreementRelationship
XXXXNumber of sexual partners by gender (past 3 months)General sex
XXXXMale sexual contacts, frequency of anal sex and condom-
less anal sex; condomless anal sex by partner serostatus,




——X—Emotional or information support from MOS, Social
Support Questionnaire 6 within TWM
TWMf-specific social support
Technology use
XXXXSocial media use, mobile phone use, service provider,
device ownership, internet access
Overall technology
TWM navigation and use
——X—System Usability Scale, reasons for using TWMTWM navigation
XXXXData captured while participants interact with TWMUser engagement
aART: antiretroviral therapy.
bIMB: information-motivation-behavioral skills.
cBSSS-4: Brief Sensation Seeking Scale-4.
dMSM: men who have sex with men.
eMOS: Medical Outcomes Study.
fTWM: Thrive with Me.
Primary Outcome
Blood draws will be taken to assess the effects of the TWM
intervention on VL, one of the most objective and reliable
indicators of ART adherence [2]. Blood will be drawn by a
certified phlebotomist and analyzed by Quest Diagnostics.
Plasma VL is considered undetectable at <20 copies/mL. Results
of VL testing is provided to participants upon request.
Demographic and HIV History
Common demographic factors will be collected, including
gender, age, race or ethnicity, sexual activity with men, income,
educational attainment, employment status, and current health
insurance. Self-reported HIV history factors include the year
and month the participant first tested positive and whether or
not they have ever received an AIDS diagnosis.
Self-Reported Antiretroviral Therapy Adherence
Participants are asked to report the medication they are currently
taking, the total number of HIV medications taken, and the
number of doses of HIV medication taken each day. Next, items
adapted from Adult AIDS Clinical Trials Group [34] and from
a more recent study by Wilson and colleagues assessing the
validity of an ART adherence scale [35] are used to assess
aspects of self-reported ART adherence. Items include the
number of dosses missed in the past 4 days and in the past 30
days, how “good of a job” participants believed they are doing
in taking their HIV medications in the way they are supposed
to (from “very poor” to “excellent”), a visual analog scale to
assess the percentage of HIV medications taken in the past 30
days and the percentage of HIV medications taken within 2
hours of the correct time in the past 30 days (both scales in 10
percent increments from 0 to 100), and what types of ART
adherence support services they are currently receiving at their
clinic.
To assess theoretically derived ART adherence strengths and
barriers, IMB-AAQ [36] will be completed by participants, as
it was in the TWM pilot trial [30,37], and by other research
teams [18,30]. The IMB-AAQ is a 33-items measure that
assesses adherence-related information (9 items), personal and
social motivation (10 items), and behavioral skills (14 items)
on a 1 to 5 Likert scale. Responses to these items will be used
to tailor the presentation of the Thrive Tips to participants as
described earlier.
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Self-Reported Engagement in HIV Care
At the 11-month and 17-month assessment, participants will be
asked to report the number of health care appointments for HIV
they scheduled and missed in the past 6 months and past 12
months, how many months ago they most recently missed an
appointment, and whether they have an HIV health care
appointment scheduled in the next 6 months. The 13-item Patient
Activation Measure [38] will be used to assess patient
knowledge, skill, and confidence for self-management of their
health care. The pattern of HIV care attendance and participants’
beliefs about the self-management of their health care will be
used to characterize their engagement in HIV care.
Substance Use and Mental Health Variables
Substance use will be assessed in two ways. First, men will take
urine screens at each assessment time point to assess for the
following illicit substances: cocaine, methamphetamines,
marijuana, opiates, and phencyclidine, using the Integrated E-Z
Split Key Cup II-5 panel (Innovacon Laboratories). This test is
capable of detecting drugs from 1 to 4 days after use, except
for chronic marijuana use, which can be detected for up to 30
days [39]. Second, using items adapted from the TWM pilot
study [30], lifetime and recent (past 6 months) use of the
following illicit drugs will be assessed: marijuana, poppers
(amyl nitrate), pain pills purchased on the street (oxycontin;
percocet), powder cocaine, crack cocaine, amphetamine,
methamphetamine, ketamine, ecstasy, heroin, cocaine and heroin
mixed together, and hallucinogens. Participants also have the
option to write in a drug not on the list. If a participant reported
taking an illicit drug(s) in the past 6 months, he was asked to
write in the number of times he used that drug(s) in the past 30
days. The Alcohol Use Disorders Identification Test (10-item
alcohol abuse scale) is used to assess problematic alcohol use
[40,41].
We will assess a broad range of mental health factors associated
with ART adherence using widely used and validated
standardized scales, including the Center for Epidemiological
Studies-Depression (10-item depression scale) [42], the
Perceived Stress Scale (14-items) [43], the 4-item Brief
Sensation Seeking Scale [44], the 6-item Life Chaos Scale [45],
and the HIV Stigma Scale [46]. In addition, 10 items from a
HIV Resiliency Scale is used to assess the ability to cope with
difficult life circumstances and positive beliefs about the self
[47].
Relationship and Sexual Risk
We will assess each participant’s current relationship status (eg,
“I am legally married” and “I am single and having sex with
others”) and, if the participant reports being in a relationship,
what agreement the participant has with his partner about sex
outside the relationship (eg, “Both of us have sex with other
separately” and “I have sex with others, but don’t know about
my partner”) from items used in a prior study by members of
the research team [48]. Next, we ask men to report the number
of sexual partners they had in the past 3 months, who were male,
female, and transgender (male and female separately). Finally,
for participants’ male sex partners, we ask them to report the
number of sexual contacts with men; the frequency of anal sex
and anal sex without a condom; condomless anal sex acts with
HIV-negative, HIV unknown, and HIV-positive partners; and
the number of condomless sex acts with HIV-negative partners
where the partner was on preexposure prophylaxis.
Social Support Variables
Two scales will be used to assess social support outside of and
inside the TWM intervention. First, the Medical Outcomes Study
(MOS) Social Support Survey (or MOS) is a validated 19-item
instrument [49] that assesses the availability of four types of
social support: emotional or informational, affectionate, tangible,
and positive social interaction on a 1 (none of the time) to 5 (all
of the time) scale. We will ask participants to complete the MOS
at all time points to assess general social support. Additionally,
we will use the 8-item emotional or informational support
subscale (eg, “Someone to turn to for suggestions about how to
deal with a personal problem”) to assess social support within
the TWM intervention at the 5-month follow-up survey. Second,
the Social Support Questionnaire 6 [50] will be used to assess
who provides support to whom in TWM and participants’ overall
satisfaction with that support. Participants in the TWM
intervention arm will be asked to indicate whether they received
six types of specific support (eg, Whom can you really count
on in the TWM study to help you feel more relaxed when you
are under pressure or tense?). If the participant stated that he
received a specific type of support, he is asked to report the
username(s) of other participants in TWM who provided that
type of support. Finally, men will be asked their overall
satisfaction with the support they received during their time in
TWM on a 6-point scale, from very dissatisfied (1) to very
satisfied (6).
Technology Adoption and Use
Technology use questions and items assessing participants’
attitudes toward technology were taken from items developed
by the Pew Research Center [51]. Men in TWM will report
whether and how frequently they use social networking service
(eg, Facebook and Instagram), what type of mobile phone they
use, their service provider, the average number of SMS (ie, text)
messages they send and receive in a month (with categorical
response options), whether they own a desktop or laptop
computer or a tablet computer, and where they access the
internet. To assess how men in the study use their mobile
phones, they are asked to state whether they have used their
mobile phone for twelve activities (eg, looked up information
about a health condition or reserve a taxi or car service).
Ease of Use of the Thrive With Me Intervention
Men randomized to the TWM intervention arm will be asked
to rate ease-of-use of the TWM using the System Usability Scale
(SUS) [52]. The SUS is a 10-item measure that asks men to rate
on a 1 (strongly disagree) to 5 (strongly agree) scale how much
they agree with statements about the ease with which they were
able to navigate TWM (eg, “I found Thrive With Me
unnecessarily complex” and “I found the various functions in
Thrive with Me to be very well integrated”). Men in the control
condition were not asked these items as they only received
weekly emails.
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Intervention use data will be collected during the active trial
period to assess user engagement with the intervention.
Intervention use data will include the following variables
reflecting peer-to-peer interaction: (1) date of post, (2) original
post content, (3) subject identity document (ID) of original post,
(4) content of replies to the original post, and (5) subject ID of
each reply. Additional user engagement variables collected are
(1) Frequency of wall posts by subject ID, (2) Number of
comments by subject ID, (3) Number of Thrive Tips viewed,
(4) Number of recommended Thrive Tips viewed, (5) Number
of responses to SMS medication reminders, (6) Number of mood
responses reported, (7) Number of weekly check-ins completed,
(8) Total number of active days, (9) Total points earned, and
(10) Total badges earned (as well as which badges earned by
participant ID).
Statistical Analysis
Analyses will be performed using Stata or SE v13 or later. The
study design is a 2 (condition: intervention vs control) X 4 (time:
baseline, 5, 11, and 17 months) randomized trial, with condition
a between-subjects effect and time a within-subjects effect. The
two primary outcomes are dichotomous: undetectable VL
(undetectable=VL <20 copies/mL vs detectable=VL >20
copies/mL) and adherence to ART (high adherence ≥90%
adherence vs low adherence <90% adherence). Mixed-effect
logistic regression models will be used to test hypotheses. These
models will include main effects for condition and time and the
condition × time interaction (a 3 degree of freedom comparison;
the overall test of the hypothesis). We will also estimate a series
of single degree-of-freedom comparisons (using planned
contrasts) to estimate the effect of the intervention on adherence
at the three postintervention follow-ups relative to baseline. We
will primarily estimate effects as intention to treat. Efficacy of
the TWM intervention will be indicated by a statistically
discernable improvement in ART adherence and VL at 17
months.
To investigate whether there is greater benefit from the TWM
intervention for drug-using participants compared with
nondrug-using participants, we will use the approach described
above with the two additional factors—self-reported current
(past 5 months) drug use and the interaction with intervention
(and time). In a similar manner, we will conduct exploratory
analyses to identify other baseline participant risk groups for
which the intervention is most beneficial. In addition, for
participants in the TWM intervention, we will examine the effect
of type and amount of intervention exposure (ie, which
component usage are related to outcomes) on improvement in
ART adherence.
Incentives
Participants are paid US $50 in cash at the end of every
in-person visit (baseline and 5-month, 11-month, 17-month
assessments). Participants in the intervention group also are
eligible to win a weekly prize drawing of a US $25 electronic
gift card. Only active users who complete actions on the TWM
site for 5 out of 10 days are eligible for the weekly prize
drawing.
Sample Size and Power Calculation
TWM will be tested in a two-arm RCT with a target N of 400
participants split equally between the intervention and control
groups. Using variance and effect size estimates from the pilot
study, power calculations determine that this sample size will
allow for an 11 percentage point detectable difference in
undetectable VL between intervention and control (eg, 71%
undetectable vs 60% undetectable) at any of the three
postintervention follow-up assessments relative to baseline
(tested using planned contrasts described above). Detectable
differences are similar for adherence and other secondary
outcomes.
Ethics Statement
All study procedures have been approved by the UMN IRB and
Hunter College City University of New York Internal Review
Board. One IRB does not cede to the other, and investigators
from each institution report to their respective IRB.
A Certificate of Confidentiality has been obtained from the
NIDA. Additionally, a DSMB has been established to provide
regular oversight of research practices and activities to protect
human subjects and the integrity of the data in the study. The
DSMB comprised independent experts in the fields of
HIV-positive populations, technology-based interventions, RCT
methodology, and social support interventions. The study is
registered on the national registry of clinical trials at
clinicaltrials.gov; trial number NCT02704208.
Results
The TWM RCT was launched in October 2016 and is ongoing.
Baseline enrollment was completed in April 2018. Follow-up
assessments will continue through August 2019.
Discussion
Adherence to HIV medication continues to be problematic, with
only 58% of HIV-positive persons aged 13 years or older in 37
states and the District of Columbia virally suppressed according
to the latest surveillance report from the US CDC [6].
Suboptimal ART adherence is the result of a complex interplay
between individual-, social-, societal-, and cultural-level factors,
and primary reasons for missed doses can vary by
sociodemographic dimensions [53-56]. Therefore, theoretically
grounded behavioral interventions are needed to address these
complex reasons for nonadherence among at-risk groups.
However, in-person ART adherence interventions are often
costly and require highly trained personnel to deliver
intervention components. The TWM intervention leverages
current mobile technologies (ie, a dynamic online website and
SMS text messaging), as well as Web 2.0 technologies that
allow users to generate and share content with each other [57],
to impact ART adherence among drug-using and nondrug using
MSM. Results of this efficacy trial would advance ART
adherence science by providing evidence for this approach and,
if effective, could inform subsequent interventions that also use
either existing (eg, Facebook) or new social media platforms.
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Technology-based behavioral interventions that use peer
interactions to promote support have the potential to be highly
engaging and use social motivation to create behavior change.
However, there is limited knowledge on how to conduct these
and other types of social media interventions. Important
questions include (1) Is it more effective to use an existing social
media platform (eg, Facebook) for intervention or develop a
private virtual community? (2) What is the optimal way to
monitor and manage activity within the community? (3) How
do we engage users with each other in virtual communities? (4)
What other features or components are needed to supplement
the community feed to maximize benefit? And (5) When do we
bring users into a virtual community (eg, immediately after
being diagnosed with HIV or only after several months of
adapting to their new diagnosis) and how frequently should
users engage in them (ie, should they continuously be engaged
or can users come in and out of the virtual community as needed)
to be most effective? These and other questions about the use
of virtual social support and other types of social media
interventions will require a sustained research effort to answer.
The lessons learned from the TWM study will begin to provide
some answers to these questions to advance intervention science
in this emerging area.
 
Acknowledgments
This work was supported by a grant from the NIDA (R01DA039950). The content is solely the responsibility of the authors and
does not represent the official views of the funding agencies. The authors would like to thank Ruben Jimenez and Ore Shalhav




1. Centers for Disease Control and Prevention. 2017 Nov 01. HIV Surveillance Report, 2016, vol 28 URL: https://www.
cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2016-vol-28.pdf [WebCite Cache ID 6zCacaIW8]
2. Panel on Antiretroviral Guidelines for Adolescents and Adults.: Department of Health and Human Services; 2018 Mar 27.
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents URL: https://aidsinfo.nih.gov/
contentfiles/lvguidelines/adultandadolescentgl.pdf [WebCite Cache ID 6zCakGQjj]
3. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in
high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008 Jul 26;372(9635):293-299 [FREE Full
text] [doi: 10.1016/S0140-6736(08)61113-7] [Medline: 18657708]
4. Cohen M, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, HPTN 052 Study Team. Prevention of
HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011 Aug 11;365(6):493-505 [FREE Full text] [doi:
10.1056/NEJMoa1105243] [Medline: 21767103]
5. Risher K, Mayer KH, Beyrer C. HIV treatment cascade in MSM, people who inject drugs, and sex workers. Curr Opin HIV
AIDS 2015 Nov;10(6):420-429 [FREE Full text] [Medline: 26352393]
6. Centers for Disease Control Prevention. 2017 Jul 01. Monitoring selected national hiv prevention and care objectives by
using HIV surveillance data - United States and 6 dependent areas, 2015 URL: https://www.cdc.gov/hiv/pdf/library/reports/
surveillance/cdc-hiv-surveillance-supplemental-report-vol-22-2.pdf [WebCite Cache ID 6zCbIk2E5]
7. Centers for Disease Control and Prevention. 2017 Jul 01. Understanding the HIV Care Continuum URL: https://www.
cdc.gov/hiv/pdf/library/factsheets/cdc-hiv-care-continuum.pdf [WebCite Cache ID 6zCbPB3XN]
8. Milam J, Richardson JL, McCutchan A, Stoyanoff S, Weiss J, Kemper C, et al. Effect of a brief antiretroviral adherence
intervention delivered by HIV care providers. J Acquir Immune Defic Syndr 2005 Nov 01;40(3):356-363. [Medline:
16249712]
9. Johnson MO, Charlebois E, Morin SF, Remien RH, Chesney MA, National Institute of Mental Health Healthy Living
Project Team. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV:
the healthy living project randomized controlled study. J Acquir Immune Defic Syndr 2007 Dec 15;46(5):574-580. [Medline:
18193499]
10. Kurth A, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, et al. Computerized counseling reduces HIV-1
viral load and sexual transmission risk: findings from a randomized controlled trial. J Acquir Immune Defic Syndr 2014
Apr 15;65(5):611-620 [FREE Full text] [doi: 10.1097/QAI.0000000000000100] [Medline: 24384803]
11. Thompson M, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, et al. Guidelines for improving entry into and
retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International
Association of Physicians in AIDS Care panel. Ann Intern Med 2012 Jun 05;156(11):817-33, W [FREE Full text] [doi:
10.7326/0003-4819-156-11-201206050-00419] [Medline: 22393036]
12. Pew Research Center. 2018 Feb 05. Internet/broadband fact sheet URL: http://www.pewinternet.org/fact-sheet/
internet-broadband/ [accessed 2018-05-05] [WebCite Cache ID 6zCbgHWN4]
JMIR Res Protoc 2018 | vol. 7 | iss. 5 | e10182 | p.16http://www.researchprotocols.org/2018/5/e10182/
(page number not for citation purposes)
Horvath et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
13. Pew Research Center. 2018 Feb 05. Mobile fact sheet URL: http://www.pewinternet.org/fact-sheet/mobile/ [accessed
2018-05-05] [WebCite Cache ID 6zCbnIobR]
14. Pew Research Center. 2018 Feb 05. Social media fact sheet URL: http://www.pewinternet.org/fact-sheet/social-media/
[accessed 2018-05-05] [WebCite Cache ID 6zCbswm3P]
15. Pellowski J, Kalichman SC. Recent advances (2011-2012) in technology-delivered interventions for people living with
HIV. Curr HIV/AIDS Rep 2012 Dec;9(4):326-334 [FREE Full text] [doi: 10.1007/s11904-012-0133-9] [Medline: 22922945]
16. Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review.
PLoS One 2011;6(11):e27533 [FREE Full text] [doi: 10.1371/journal.pone.0027533] [Medline: 22140446]
17. Page T, Horvath KJ, Danilenko GP, Williams M. A cost analysis of an Internet-based medication adherence intervention
for people living with HIV. J Acquir Immune Defic Syndr 2012 May 01;60(1):1-4 [FREE Full text] [doi:
10.1097/QAI.0b013e318250f011] [Medline: 22362156]
18. Fisher J, Amico KR, Fisher WA, Cornman DH, Shuper PA, Trayling C, LifeWindows Team. Computer-based intervention
in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav 2011
Nov;15(8):1635-1646. [doi: 10.1007/s10461-011-9926-x] [Medline: 21452051]
19. Muessig K, LeGrand S, Horvath KJ, Bauermeister JA, Hightow-Weidman LB. Recent mobile health interventions to support
medication adherence among HIV-positive MSM. Curr Opin HIV AIDS 2017 Sep;12(5):432-441. [doi:
10.1097/COH.0000000000000401] [Medline: 28639990]
20. Horvath K. Using technology to assess and intervene with illicit drug-using persons at risk for HIV. Curr Opin HIV AIDS
2017;12(5):458-466. [doi: 10.1097/COH.0000000000000398]
21. Simoni J, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting
antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol 2007
Jul;26(4):488-495 [FREE Full text] [doi: 10.1037/0278-6133.26.4.488] [Medline: 17605569]
22. Simoni J, Huh D, Frick PA, Pearson CR, Andrasik MP, Dunbar PJ, et al. Peer support and pager messaging to promote
antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr 2009 Dec
01;52(4):465-473 [FREE Full text] [Medline: 19911481]
23. Fisher W, Fisher JD, Harman JJ. The information–motivation– behavioral skills model: a general social psychological
approach to understanding and promoting health behavior. In: Social Psychological Foundations of Health and Illness.
Malden, MA: Blackwell Publishing Ltd; 2003:82-106.
24. Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of
antiretroviral therapy adherence. AIDS Care 2005 Aug;17(6):661-673. [doi: 10.1080/09540120500038058] [Medline:
16036253]
25. Horvath KJ, Oakes JM, Rosser BR, Danilenko G, Vezina H, Amico KR, et al. Feasibility, acceptability and preliminary
efficacy of an online peer-to-peer social support ART adherence intervention. AIDS Behav 2013 Jul;17(6):2031-2044
[FREE Full text] [doi: 10.1007/s10461-013-0469-1] [Medline: 23553347]
26. Fisher JD, Fisher WA, Williams SS, Malloy TE. Empirical tests of an information-motivation-behavioral skills model of
AIDS-preventive behavior with gay men and heterosexual university students. Health Psychol 1994 May;13(3):238-250.
[Medline: 8055859]
27. Fisher WA, Fisher JD, Harman J. The information-motivation-behavioral skills model: A general social psychological
approach to understanding and promoting health behavior. In: Blackwell series in health psychology and behavioral medicine.
Social psychological foundations of health and illness. Malden: Blackwell Publishing; 2003:82-106.
28. Starace F, Massa A, Amico KR, Fisher JD. Adherence to antiretroviral therapy: an empirical test of the
information-motivation-behavioral skills model. Health Psychol 2006 Mar;25(2):153-162. [doi: 10.1037/0278-6133.25.2.153]
[Medline: 16569106]
29. Amico KR, Barta W, Konkle-Parker DJ, Fisher JD, Cornman DH, Shuper PA, et al. The information-motivation-behavioral
skills model of ART adherence in a Deep South HIV+ clinic sample. AIDS Behav 2009 Feb;13(1):66-75 [FREE Full text]
[doi: 10.1007/s10461-007-9311-y] [Medline: 17876697]
30. Horvath KJ, Oakes JM, Rosser BRS, Danilenko G, Vezina H, Amico KR, et al. Feasibility, acceptability and preliminary
efficacy of an online peer-to-peer social support ART adherence intervention. AIDS Behav 2013 Jul;17(6):2031-2044
[FREE Full text] [doi: 10.1007/s10461-013-0469-1] [Medline: 23553347]
31. Horvath KJ, Smolenski D, Amico KR. An empirical test of the information-motivation-behavioral skills model of ART
adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. AIDS Care 2014 Feb;26(2):142-151
[FREE Full text] [doi: 10.1080/09540121.2013.802283] [Medline: 23724908]
32. Wiewell E, McAllister‐Hollod L. Nyhiv. 2013 Jun 13. HIV care cascades for New York City overall and Ryan White
clients: A first look URL: http://www.nyhiv.org/pdfs/NAC%20Presentation%206-13-13.pdf [accessed 2018-05-05] [WebCite
Cache ID 6zCct2R40]
33. Zlotorzynska M, Sullivan P, Sanchez T. The annual American men's internet survey of behaviors of men who have sex
with men in the United States: 2015 key indicators report. JMIR Public Health Surveill 2017 Mar 25;3(1):e13 [FREE Full
text] [doi: 10.2196/publichealth.7119] [Medline: 28356240]
JMIR Res Protoc 2018 | vol. 7 | iss. 5 | e10182 | p.17http://www.researchprotocols.org/2018/5/e10182/
(page number not for citation purposes)
Horvath et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
34. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral
medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee &
Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care
2000 Jun;12(3):255-266. [doi: 10.1080/09540120050042891] [Medline: 10928201]
35. Wilson IB, Fowler FJ, Cosenza CA, Michaud J, Bentkover J, Rana A, et al. Cognitive and field testing of a new set of
medication adherence self-report items for HIV care. AIDS Behav 2014 Dec;18(12):2349-2358 [FREE Full text] [doi:
10.1007/s10461-013-0610-1] [Medline: 24077970]
36. The LifeWindows Project Team. 2006. The lifewindows information motivation behavioral skills ART adherence
questionnaire (LW-IMB-AAQ) URL: https://chipcontent.chip.uconn.edu/chipweb/documents/Research/
F_LWIMBARTQuestionnaire.pdf [WebCite Cache ID 6zCd7p9Bp]
37. Horvath K, Smolenski D, Amico KR. An empirical test of the information-motivation-behavioral skills model of ART
adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. AIDS Care 2014 Feb;26(2):142-151
[FREE Full text] [doi: 10.1080/09540121.2013.802283] [Medline: 23724908]
38. Hibbard J, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure.
Health Serv Res 2005 Dec;40(6 Pt 1):1918-1930 [FREE Full text] [doi: 10.1111/j.1475-6773.2005.00438.x] [Medline:
16336556]
39. Cone E. New developments in biological measures of drug prevalence. NIDA Res Monogr 1997;167:108-129. [Medline:
9243559]
40. Saunders JB, Aasland OG, Babor TF, de LFJR, Grant M. Development of the alcohol use disorders identification test
(AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II. Addiction 1993
Jun;88(6):791-804. [Medline: 8329970]
41. Leonhard C, Mulvey K, Gastfriend DR, Shwartz M. The addiction severity index: a field study of internal consistency and
validity. J Subst Abuse Treat 2000 Mar;18(2):129-135. [Medline: 10716096]
42. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas
1992;1(3):385-401. [doi: 10.1177/014662167700100306]
43. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983 Dec;24(4):385-396.
[Medline: 6668417]
44. Stephenson MT, Hoyle RH, Palmgreen P, Slater MD. Brief measures of sensation seeking for screening and large-scale
surveys. Drug Alcohol Depend 2003 Dec 11;72(3):279-286. [Medline: 14643945]
45. Wong M, Sarkisian CA, Davis C, Kinsler J, Cunningham WE. The association between life chaos, health care use, and
health status among HIV-infected persons. J Gen Intern Med 2007 Sep;22(9):1286-1291 [FREE Full text] [doi:
10.1007/s11606-007-0265-6] [Medline: 17597350]
46. Earnshaw V, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH:
a test of the HIV stigma framework. AIDS Behav 2013 Jun;17(5):1785-1795 [FREE Full text] [doi:
10.1007/s10461-013-0437-9] [Medline: 23456594]
47. Mosack K. E. , Developmentvalidation of the R-PLA: A resiliency measure for people living with HIV/AIDS (immune
deficiency) 2002;Learning:A.
48. Parsons JT, Starks TJ, DuBois S, Grov C, Golub SA. Alternatives to monogamy among gay male couples in a community
survey: implications for mental health and sexual risk. Arch Sex Behav 2013 Feb;42(2):303-312 [FREE Full text] [doi:
10.1007/s10508-011-9885-3] [Medline: 22187028]
49. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32(6):705-714. [Medline: 2035047]
50. Sarason I, Sarason BR, Shearin EN, Pierce GR. A brief measure of social support: practical and theoretical implications. ‎J
Soc Pers Relatsh 1987;4(4):497-510. [doi: 10.1177/0265407587044007]
51. Pew Research Center. 2018. Internet and Technology URL: http://www.pewinternet.org/ [WebCite Cache ID 6zKtaYqJJ]
52. Brook J. A quick and dirty usability scale, in usability evaluation in industry. London: Taylor Francis; 1996.
53. Sauceda J, Neilands TB, Johnson MO, Saberi P. An update on the barriers to adherence and a definition of self-report
non-adherence given advancements in antiretroviral therapy (ART). AIDS Behav 2018 Mar;22(3):939-947. [doi:
10.1007/s10461-017-1759-9] [Medline: 28352983]
54. Amico K, Konkle-Parker DJ, Cornman DH, Barta WD, Ferrer R, Norton WE, et al. Reasons for ART non-adherence in the
Deep South: adherence needs of a sample of HIV-positive patients in Mississippi. AIDS Care 2007 Nov;19(10):1210-1218
[FREE Full text] [doi: 10.1080/09540120701426516] [Medline: 18071964]
55. Kalichman SC, Eaton L, Kalichman MO, Grebler T, Merely C, Welles B. Race-based medical mistrust, medication beliefs
and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS. J Behav Med 2016
Dec;39(6):1056-1064 [FREE Full text] [doi: 10.1007/s10865-016-9767-1] [Medline: 27392477]
56. Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non-adherence to
antiretroviral therapy. AIDS Care 2017 Apr;29(4):418-422 [FREE Full text] [doi: 10.1080/09540121.2016.1220478]
[Medline: 27535297]
JMIR Res Protoc 2018 | vol. 7 | iss. 5 | e10182 | p.18http://www.researchprotocols.org/2018/5/e10182/
(page number not for citation purposes)
Horvath et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
57. Muessig KE, Nekkanti M, Bauermeister J, Bull S, Hightow-Weidman LB. A systematic review of recent smartphone,
internet and Web 2.0 interventions to address the HIV continuum of care. Curr HIV/AIDS Rep 2015 Mar;12(1):173-190




CAB: community advisory board
CASI: computer-assisted survey instrument
CDC: Centers for Disease Control and Prevention
CHEST: Center for HIV Educational Studies and Training
DSMB: data safety and monitoring board
IMB: information-motivation-behavioral skills
IRB: institutional review board
MOS: Medical Outcomes Study
MSM: men who have sex with men
NIDA: National Institute on Drug Abuse
PI: principal investigator
PLWH: people living with HIV or AIDS
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